BORREGAARD BIOPLANT ApS: Financial statements 2023
CVR: 21500445
BORREGAARD BIOPLANT ApS (CVR 21500445) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 9,116,413 and a net result of DKK -753,841 compared with DKK -1,458,607 the year before. That is a decrease of 8.9% compared with the year before. Equity amounted to DKK 5,608,145. The solvency ratio was 57.7%. The company had 22 employees in the financial year.
- Gross Profit
- 9,116,413 kr.
- Profit/Loss
- -753,841 kr.
- Equity
- 5,608,145 kr.
- Total Assets
- 9,727,442 kr.
- Employees
- 22
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 9.1 mio. | -754 t. | 5.6 mio. | 22 |
| 2022 | - | 10 mio. | -1.5 mio. | 7.4 mio. | 21 |
| 2021 | - | 11.8 mio. | 900 t. | 9.8 mio. | 20 |
| 2020 | - | 11.5 mio. | 596 t. | 8.9 mio. | 19 |
| 2019 | - | 9.1 mio. | 211 t. | 8.3 mio. | 20 |
Events in 2023
BORREGAARD BIOPLANT ApS has published its annual report for 2022. Gross profit came to DKK 10,002,306, and the net result was DKK -1,458,607.
As of January 1, 2023, Martin Lemche is registered as director of BORREGAARD BIOPLANT ApS.
About BORREGAARD BIOPLANT ApS
BORREGAARD BIOPLANT ApS is a Danish company of the type Anpartsselskab based in Aarhus N, founded in 1999. The company is registered under the industry Ikke-specialiseret engroshandel. The management consists of Martin Lemche. The company is owned by Biobest Group NV. The company has 18 employees. In 2025, the company reported a gross profit of DKK 10,536,766 and a net result of DKK 491,045 compared with DKK 421,195 the year before. Equity amounted to DKK 5,520,385.